David Zloty

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

Brigitte Dréno, Rainer Kunstfeld, Axel Hauschild et al. · The Lancet Oncology · 2017 · 206 citations

Medicine, Oncology, Pharmacology +12

CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas

Blanche K.K. Lo, Mei Yu, David Zloty et al. · American Journal Of Pathology · 2010 · 119 citations · Full text

Medicine, Cancer Biology, Oncology +11

Superficial, Nodular, and Morpheiform Basal-Cell Carcinomas Exhibit Distinct Gene Expression Profiles

Mei Yu, David Zloty, Bryce J. Cowan et al. · Journal of Investigative Dermatology · 2008 · 55 citations · Full text

Medicine, Oncology, Pathology +10

Non-melanoma Skin Cancer in Canada Chapter 5: Management of Squamous Cell Carcinoma

Mariusz Sapijaszko, David Zloty, Marc Bourcier et al. · Journal of Cutaneous Medicine and Surgery · 2015 · 39 citations

Medicine, Dermatology, Oncology +17

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

David Zloty, Lyn Guenther, Mariusz Sapijaszko et al. · Journal of Cutaneous Medicine and Surgery · 2015 · 38 citations

Medicine, Dermatology, Surgery +17